VOLITIONRX LTD — Director's Dealing 2013

Aug 27, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2012-12-31

Reporting Person: Faulkes Martin Charles (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	926067	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
WARRANT	$1.05	2016-07-13	COMMON STOCK (250000)	250000	Direct
OPTION	$3	2015-05-25	COMMON STOCK (5000)	5000	Direct
OPTION	$3	2015-11-25	COMMON STOCK (5000)	5000	Direct
OPTION	$4	2016-05-25	COMMON STOCK (5000)	5000	Direct
OPTION	$4	2016-11-25	COMMON STOCK (5000)	5000	Direct
OPTION	$5	2017-05-25	COMMON STOCK (5000)	5000	Direct
OPTION	$5	2017-11-25	COMMON STOCK (5000)	5000	Direct
WARRANT	$2.6	2016-05-10	COMMON STOCK (58034)	58034	Direct

Footnotes

F1: On October 6, 2011, Dr. Martin Faulkes was appointed as a member of the Board of Directors of the Company.

F2: $1.75 Unit Price paid for 116,067 shares of common stock reported in Table 1, which included a Warrant to purchase 58,034 shares of common stock at $2.60 for four years.